AstraZeneca is a U.K.-based global biopharmaceutical company that develops and markets prescription medicines in oncology, cardiovascular, respiratory, and other therapy areas.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Larry Robbins / Glenview | 58 | New buy | 184,279 | $34,942,984 | 0.6% |
| Paul Tudor Jones / Tudor | 63 | Added +199% | 51,144 | $9,697,925 | 0.0% |
| Steve Cohen / Point72 | 76 | Trimmed -41% | 743,947 | $141,067,230 | 0.2% |
| Ancora | 40 | Trimmed -48% | 798 | $151,317 | 0.0% |
| Trade date | Who | Type | Amount | |
|---|---|---|---|---|
| 2026-03-31 | Alan Armstrong senate | BUY | $1,001 - $15,000 | PTR |
| 2026-03-30 | Alan Armstrong senate | BUY | $15,001 - $50,000 | PTR |
| 2025-12-18 | Gilbert Cisneros CA31 | BUY | $1,001 - $15,000 | PTR |
| 2025-12-08 | Julia Letlow LA05 | BUY | $1,001 - $15,000 | PTR |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.